Are a treatment option for hypertensive patients with concomitant heart disease or heart failure. MOA: reduce blood pressure by: 1 decreasing cardiac output 2 decrease sympathetic outflow from the CNS 3 inhibit release of renin from the kidneys, thus decreasing the formation of angiotensin II and the secretion of aldosterone